In this case, the gene encoding T7 RNA polymerase was added to the SpudCell genome, and it was made by those artificial cells ...

Seeking a share of the first-line diffuse large B-cell lymphoma (DLBCL) market, Incyte believes Monjuvi’s positive phase 3 results across patient subgroups will give it an edge over the standard ...

Learn how to create a beautiful handmade ring step by step with this simple and satisfying jewelry tutorial. Perfect for beginners and DIY jewelry lovers. #JewelryMaking #DIYRing #HandmadeJewelry ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Antigen-presenting cells activate invariant natural killer T (iNKT) cells, and this combination with α-galactosylceramide subsequently activates the body’s own T cells to fight tumors. This image was ...

Subcutaneous mosunetuzumab with step-up dosing plus six cycles of polatuzumab vedotin enabled fully outpatient delivery without mandatory hospitalization, aligning with access and cost-reduction goals ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. The longtime Tiffany & Co.

Combo Devils, a recently kickstarted platform fighter from developer Punkzilla, has one of the best elevator pitches of any fighting game I’ve played in a hot minute: What if we took the core of Smash ...

Randomization enrolled 1841 systemic-therapy–naïve patients within 12 weeks post-surgery to 1 year pembrolizumab plus daily belzutifan or placebo. Disease-free survival improved despite unreached ...

Both trials are ongoing and will report on overall survival at a subsequent analysis. Findings showed the trial met its primary endpoint demonstrating a statistically significant and clinically ...